Last reviewed · How we verify

NCT07473349

Diagnostic Accuracy of Clinical Tests and Diagnostic Criteria for Piriformis Syndrome

Not yet recruiting NA Last updated 17 March 2026
What this trial tests

NA trial testing Ultrasound-Guided Piriformis Injection in Piriformis Syndrome in 75 participants. Not yet recruiting.

Timeline
15 March 2026
Primary endpoint
15 September 2026
15 September 2026

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment75
Start date15 March 2026
Primary completion15 September 2026
Estimated completion15 September 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 18 to 75, any sex, with Piriformis Syndrome or Gluteal Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Piriformis syndrome is a clinical condition characterized by buttock pain and/or sciatic-like symptoms, and its diagnosis remains challenging because there is no universally accepted diagnostic standard. This study aims to evaluate the diagnostic accuracy of commonly used diagnostic criteria and clinical tests for piriformis syndrome. Participants with suspected piriformis syndrome will undergo standardized physical examination and assessment of predefined diagnostic criteria. Ultrasound-guided injection of 5 mL of 2% lidocaine into the piriformis muscle will be used as the reference diagnostic procedure. A reduction of 50% or more in pain after injection will be considered confirmation of piriformis syndrome. The diagnostic performance of clinical tests and diagnostic criteria will be analyzed accordingly.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Piriformis Syndrome

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07473349.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing